Kapruvia receives positive CHMP opinion for the treatment of moderate-to-severe pruritus in…
The European Medicines Agency's (EMA) CHMP has recommended approval of Kapruvia (difelikefalin) for the treatment of moderate-to-severe pruritus associated with chronic kidney disease…
Read More...
Read More...